Michael Nofi
Vermogen: - $ op 31-08-2026
Vermogen: - $ op 31-08-2026
Michael P.
Nofi is currently Chief Financial Officer at Parlux Fragrances LLC and will be Chief Financial Officer at Edgewise Therapeutics, Inc. starting in 2025.
Formerly, Mr. Nofi was Chief Financial Officer at Perfumania Holdings, Inc. from 2017 to 2018 and Chief Accounting Officer at Springworks Therapeutics, Inc. from 2019 to 2025.
Mr. Nofi completed undergraduate studies at Villanova University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 12-08-2026 | 0 ( -.--% ) | - $ | 31-08-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| EDGEWISE THERAPEUTICS, INC. | Financieel Directeur/CFO | 10-11-2025 |
Parlux Fragrances LLC
Parlux Fragrances LLC Household/Personal CareConsumer Non-Durables Manufactures a broad line of toiletries, perfumes and colognes | Financieel Directeur/CFO | - |
| Bedrijven | Functie | Einde |
|---|---|---|
| SPRINGWORKS THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01-07-2025 |
| PERFUMANIA HOLDINGS, INC. | Financieel Directeur/CFO | 01-10-2018 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Parlux Fragrances LLC
Parlux Fragrances LLC Household/Personal CareConsumer Non-Durables Manufactures a broad line of toiletries, perfumes and colognes | Consumer Non-Durables |
Perfumania Holdings, Inc.
Perfumania Holdings, Inc. Specialty StoresRetail Trade Retails and distributes perfumes & fragrances | Retail Trade |
Villanova University
Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Edgewise Therapeutics, Inc.
Edgewise Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies for skeletal muscle diseases | Health Technology |
Springworks Therapeutics, Inc.
Springworks Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes medicines for nervous system disorders | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau